CDK4 amplification has been observed in several malignancies including glioma, breast cancer, and lung cancer [24], and an absence of CDK4 amplification in WD and DD liposarcomas is associated with lower rate of recurrence and favorable prognosis [47]. The gene discussed is CDK4; the disease is lung cancer.